These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 15540563

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Capabilities of hypoglycemic therapy in women with decompensated type 2 diabetes mellitus].
    Onuchin SG, Elsukova OS, Solov'ev OV, Onuchina EL.
    Ter Arkh; 2010; 82(8):34-41. PubMed ID: 20873243
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, Palumbo I, D'Angelo A, Cicero AF.
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [Abstract] [Full Text] [Related]

  • 6. Metformin and pioglitazone: Effectively treating insulin resistance.
    Staels B.
    Curr Med Res Opin; 2006 Aug; 22 Suppl 2():S27-37. PubMed ID: 16914073
    [Abstract] [Full Text] [Related]

  • 7. [Insulin sparing and metabolic control with metformin-insulin combination].
    Isnard F.
    Journ Annu Diabetol Hotel Dieu; 1997 Aug; ():305-25. PubMed ID: 9296986
    [No Abstract] [Full Text] [Related]

  • 8. Thiazolidinediones in type 2 diabetes: a cardiology perspective.
    Khanderia U, Pop-Busui R, Eagle KA.
    Ann Pharmacother; 2008 Oct; 42(10):1466-74. PubMed ID: 18698014
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sitagliptin: a novel drug for the treatment of type 2 diabetes.
    Choy M, Lam S.
    Cardiol Rev; 2007 Oct; 15(5):264-71. PubMed ID: 17700385
    [Abstract] [Full Text] [Related]

  • 11. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.
    Strowig SM, Raskin P.
    Diabetes Obes Metab; 2005 Nov; 7(6):633-41. PubMed ID: 16219007
    [Abstract] [Full Text] [Related]

  • 12. [Triple oral therapy in type 2 diabetes].
    Scheen AJ.
    Rev Med Suisse; 2005 Aug 24; 1(30):1942, 1944-6, 1948. PubMed ID: 16200937
    [Abstract] [Full Text] [Related]

  • 13. Pioglitazone, rosiglitazone, and rosiglitazone + metformin: new drugs. Glitazone + oral antidiabetic combination: inadequately evaluated.
    Prescrire Int; 2005 Aug 24; 14(78):133-9. PubMed ID: 16106595
    [Abstract] [Full Text] [Related]

  • 14. A fixed-dose combination of pioglitazone and metformin: A promising alternative in metabolic control.
    Seufert J.
    Curr Med Res Opin; 2006 Aug 24; 22 Suppl 2():S39-48. PubMed ID: 16914074
    [Abstract] [Full Text] [Related]

  • 15. Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus.
    Teranishi T, Ohara T, Maeda K, Zenibayashi M, Kouyama K, Hirota Y, Kawamitsu H, Fujii M, Sugimura K, Kasuga M.
    Metabolism; 2007 Oct 24; 56(10):1418-24. PubMed ID: 17884455
    [Abstract] [Full Text] [Related]

  • 16. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.
    Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, Le Winter M, Porte D, Semenkovich CF, Smith S, Young LH, Kahn R, American Heart Association, American Diabetes Association.
    Circulation; 2003 Dec 09; 108(23):2941-8. PubMed ID: 14662691
    [No Abstract] [Full Text] [Related]

  • 17. Management of diabetes during Ramadan.
    Whitelaw D.
    Diabet Med; 2005 Sep 09; 22 Suppl 4():21-3. PubMed ID: 16109015
    [No Abstract] [Full Text] [Related]

  • 18. [Controversial therapeutic strategies in the treatment of type 2 diabetes mellitus].
    Schumm-Draeger PM.
    MMW Fortschr Med; 2005 Apr 28; 147(17):32-4, 36. PubMed ID: 15903057
    [Abstract] [Full Text] [Related]

  • 19. Pioglitazone in a subgroup of patients with type 2 diabetes meeting the criteria for metabolic syndrome.
    Lester JW, Fernandes AW.
    Int J Clin Pract; 2005 Feb 28; 59(2):134-42. PubMed ID: 15854187
    [Abstract] [Full Text] [Related]

  • 20. A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial.
    Charbonnel BH, Matthews DR, Schernthaner G, Hanefeld M, Brunetti P, QUARTET Study Group.
    Diabet Med; 2005 Apr 28; 22(4):399-405. PubMed ID: 15787663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.